![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Jiangsu Tianhe Pharmaceutical Co., Ltd Yangzhou City Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Levamisole Hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-498 - Rev 00
This Chemical Type CEP, issued on March 26, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 726 associated with this CEP further emphasizes